Skip to main content
. 2017 Apr 10;6(4):e313. doi: 10.1038/oncsis.2017.13

Figure 4.

Figure 4

MnSOD is induced by MCT-1 overexpression, p53 knockdown and EGFR activation. (a) MnSOD expression was examined in MCF-10A cells (control and MCT-1) with (shp53) or without (scramble) p53 depletion. (b) Cellular ROS levels were analyzed in MCF-10A cells with different conditions of p53 and MCT-1 expression upon DMSO or AG1478 treatment. Data represent the mean±s.d. (n=3). **P<0.01; ***P<0.001. (c) MnSOD levels were characterized in the H1299 cells (control and MCT-1) without (pCMV) or with p53 re-expression (pCMV p53). (d) The EGFR phosphorylation and MnSOD levels were assessed when H1299 cells were introducing empty vector, wild-type EGFR and EGFR-activating mutants (L858R and exon19 DEL). (e) MDA-MB231 cells with or without MCT-1 overexpression were assayed. (f) MDA-MB231 cells with or without MCT-1 knockdown were evaluated. The protein amounts were normalized to β-actin or GAPDH, and the phosphorylated EGFR levels were normalized to total EGFR levels before comparison with the comparative controls (lane 1).